Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
Recruiting · NCT04761393 · Registry updated 2024-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum | Pathologic Processes, Pathological Conditions, Signs and Symptoms, pulmonary emphysema | Recruiting | Not stated | 2024-11-20 | NCT04761393 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Foresee Pharmaceuticals Co., Ltd. | 3 |
| McMaster University | 202 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Firestone Institute for Respiratory Health, St. Joseph's Healthcare | Hamilton | Canada | 1 |